儿茶酚氧位甲基转移酶基因G1947A多态性与吸烟行为相关性的Meta分析

doi:10.6040/j.issn.1671-7554.0.2018.1426

摘要/Abstract

摘要： 目的探讨儿茶酚氧位甲基转移酶(COMT)基因G1947A多态性与吸烟行为之间的关系。方法检索自建库至2018年11月PubMed,EMBASE,Web of Science和Cochrane Library数据库,严格按照纳入和排除标准筛选文献。进行Meta分析计算组合效应值及其95%可信区间(CI)。进行亚组分析探讨性别和种族之间的差异。结果最终纳入文献16篇,其中包括7565名当前吸烟者、6 491名已经戒烟者、9 370名从未吸烟者、14 535名吸过烟者和16 140名当前不吸烟者。在显性模型中发现,COMT基因G1947A中的等位基因A可以降低总体人群吸过烟的风险(OR=0.92,95% CI=0.85~0.98,P=0.014),尤其是亚洲人群(OR=0.77,95% CI=0.62~0.93,P=0.025)。COMT基因G1947A多态性与目前是否吸烟和戒烟状态的关系在3种模型中均无显著差异(P>0.05)。敏感性分析、影响性分析对现有结果无实质影响,且没有检测到发表偏倚。结论 COMT基因G1947A中的A等位基因对总体人群初始不吸烟具有保护作用。

关键词: 吸烟, 儿茶酚氧位甲基转移酶, 基因, 多态性, Meta分析

Abstract: Objective To explore the relationship between catechol-O-methyl transferase(COMT)gene G1947A polymorphism and smoking behavior. Methods Relevant literature were searched in PubMed, EMBASE, Web of Science and Cochrane Library from inception up to Nov. 2018. Data were strictly screened according to the inclusion and exclusion criteria. The combined effect values and the 95% confidence intervals (CI) were calculated based on Meta-analysis. The differences in gender and ethnicity were investigated with subgroup analysis. Results A total of 16 researches were included, with 7 565 current smokers, 6 491 ex-smokers, 9 370 never smokers, 14 535 ever smokers and 16 140 nonsmokers involved. Significant effects of smoking initiation with COMT G1947A polymorphism were found in the dominant model(OR=0.92, 95%CI=0.85-0.98, P=0.014), especially in Asians(OR=0.77, 95%CI=0.62-0.93, P=0.025). The associations of COMT G1947A polymorphism with smoking persistence and cessation were not significant in the 3 models. After sensitivity and influence analyses, the pooled results did not change substantially. No publication bias was detected. Conclusion The A allele in COMT G1947A has a modest protective effect for smoking initiation.

Key words: Smoking behavior, Catechol-O-methyl transferase, Gene, Polymorphism, Meta-analysis

中图分类号:

殷晓霖,杨孝荣,张同超,满金宇,吕明. 儿茶酚氧位甲基转移酶基因G1947A多态性与吸烟行为相关性的Meta分析[J]. 山东大学学报 (医学版), 2019, 57(2): 110-116.

YIN Xiaolin, YANG Xiaorong, ZHANG Tongchao, MAN Jinyu, LÜ Ming. Association of catechol-O-methyl transferase gene G1947A polymorphism with smoking behavior: a Meta-analysis[J]. Journal of Shandong University (Health Sciences), 2019, 57(2): 110-116.

参考文献

[1] World Health Organization. WHO report on the global tobacco epidemic 2017: monitoring tobacco use and prevention policies[M]. Geneva: World Health Organization, 2017.
[2] Wu J, Gao M, Shen JX, et al. Cortical control of VTA function and influence on nicotine reward[J]. Biochem Pharmacol, 2013, 86(8): 1173-1180.
[3] Dani JA, De Biasi M. Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal[J]. Cold Spring Harb Perspect Med, 2013, 3(6): a012138.
[4] Herman AI, DeVito EE, Jensen KP, et al. Pharmacogenetics of nicotine addiction: role of dopamine[J]. Pharmacogenomics, 2014, 15(2): 221-234.
[5] Zubieta JK, Heitzeg MM, Smith YR, et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor[J]. Science, 2003, 299(5610): 1240-1243.
[6] Tochigi M, Suzuki K, Kato C, et al. Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior[J]. Pharmacogenet Genomics, 2007, 17(10): 867-872.
[7] Shiels MS, Huang HY, Hoffman SC, et al. A community-based study of cigarette smoking behavior in relation to variation in three genes involved in dopamine metabolism: Catechol-O-methyltransferase(COMT), dopamine beta-hydroxylase(DBH)and monoamine oxidase-A(MAO-A)[J]. Prev Med, 2008, 47(1): 116-122.
[8] Tang X, Guo S, Sun HQ, et al. Gene-gene interactions of CYP2A6 and MAOA polymorphisms on smoking behavior in Chinese male population[J]. Pharmacogenet Genomics, 2009, 19(5): 345-352.
[9] Beuten J, Payne TJ, Ma JZ, et al. Significant association of catechol-O-methyltransferase(COMT)haplotypes with nicotine dependence in male and female smokers of two ethnic populations[J]. Neuropsychopharmacology, 2006, 31(3): 675-684.
[10] Nedic G, Nikolac M, Borovecki F, et al. Association study of a functional catechol-O-methyltransferase polymorphism and smoking in healthy Caucasian subjects[J]. Neurosci Lett, 2010, 473(3): 216-219.
[11] Colilla S, Lerman C, Shields PG, et al. Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women[J]. Pharmacogenet Genomics, 2005, 15(6): 393-398.
[12] Wells GA, Shea B, O’connell D, et al. The Newcastle-Ottawa Scale(NOS)for assessing the quality of nonrandomised studies in meta-analyses[EB/OL]. [2018-11-15]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
[13] Munafò MR, Timpson NJ, David SP, et al. Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data[J]. Nicotine Tob Res, 2009, 11(1): 64-76.
[14] Ohmoto M, Sakaishi K, Hama A, et al. Association between dopamine receptor 2 TaqIA polymorphisms and smoking behavior with an influence of ethnicity: a systematic review and meta-analysis update[J]. Nicotine Tob Res, 2013, 15(3): 633-642.
[15] Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints[J]. Stat Med, 2006, 25(20): 3443-3457.
[16] Suriyaprom K, Tungtrongchitr R, Harnroongroj T. Impact of COMT Val(108/158)Met and DRD2 Taq1B gene polymorphisms on vulnerability to cigarette smoking of Thai males[J]. J Mol Neurosci, 2013, 49(3): 544-549.
[17] Ou WC, Huang YC, Huang CL, et al. Interaction between cytochrome P450 2A6 and Catechol-O-Methyltransferase genes and their association with smoking risk in young men[J]. Behav Brain Funct, 2017, 13(1): 8.
[18] Nedic G, Nikolac M, Borovecki F, et al. Association study of a functional catechol-O-methyltransferase polymorphism and smoking in healthy Caucasian subjects[J]. Neurosci Lett, 2010, 473(3): 216-219.
[19] Mutschler J, Abbruzzese E, von der Goltz C, et al. Lack of association of a functional catechol-O-methyltransferase gene polymorphism with risk of tobacco smoking: results from a multicenter case-control study[J]. Nicotine Tob Res, 2013, 15(7): 1322-1327.
[20] Munafò MR, Freathy RM, Ring SM, et al. Association of COMT Val(108/158)Met genotype and cigarette smoking in pregnant women[J]. Nicotine Tob Res, 2011, 13(2): 55-63.
[21] Ton TG, Rossing MA, Bowen DJ, et al. Genetic polymorphisms in dopamine-related genes and smoking cessation in women: a prospective cohort study[J]. Behav Brain Funct, 2007, 3: 22. doi:10.1186/1744-9081-3-22.
[22] Johnstone EC, Elliot KM, David SP, et al. Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial[J]. Cancer Epidemiol Biomarkers Prev, 2007, 16(6): 1065-1069.
[23] Enoch MA, Waheed JF, Harris CR, et al. Sex differences in the influence of COMT Val158Met on alcoholism and smoking in plains American Indians[J]. Alcohol Clin Exp Res, 2006, 30(3): 399-406.
[24] Kakino K, Kiyohara C, Horiuchi T, et al. CYP2E1 rs2031920, COMT rs4680 polymorphisms, cigarette smoking, alcohol use and lung cancer risk in a Japanese population[J]. Asian Pac J Cancer Prev, 2016, 17(8): 4063-4070.
[25] Breitling LP, Dahmen N, Illig T, et al. Variants in COMT and spontaneous smoking cessation: retrospective cohort analysis of 925 cessation events[J]. Pharmacogenet Genomics, 2009, 19(8): 657-659.
[26] David SP, Johnstone E, Griffiths SE, et al. No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation[J]. Pharmacogenetics, 2002, 12(3): 265-268.
[27] Kótyuk E, Kovács-Nagy R, Faludi G, et al. Association between nicotine dependence and the -521 promoter polymorfism of the dopamine D4 receptor in patients with major depression[J]. Neuropsychopharmacol Hung, 2009, 11(2): 59-67.
[28] Omidvar M, Stolk L, Uitterlinden AG, et al. The effect of catechol-O-methyltransferase Met/Val functional polymorphism on smoking cessation: retrospective and prospective analyses in a cohort study[J]. Pharmacogenet Genomics, 2009, 19(1): 45-51.
[29] Choi HD, Shin WG. Association between catechol-O-methyltransferase(COMT)Val/Met genotype and smoking cessation treatment with nicotine: a meta-analysis[J]. Pharmacogenomics, 2015, 16(16): 1879-1885.
[30] Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature[J]. J Clin Epidemiol, 2000, 53(11): 1119-1129.
[31] Tunbridge EM, Weickert CS, Kleinman JE, et al. Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan[J]. Cereb Cortex, 2007, 17(5): 1206-1212.

相关文章 15

[1]	张士宝刘庆勇阮喜云陈杰张建军李宗武杨广笑王全颖. NT₄-SAC-HA₂-TAT融合基因表达载体的构建及鉴定[J]. 山东大学学报(医学版), 2209, 47(6): 15-19.
[2]	葛丽娟金瑞峰王纪文许新升李癊. 多药耐药基因1 C1236T多态性与癫痫患者对药物反应性的相关性[J]. 山东大学学报(医学版), 2209, 47(6): 99-102.
[3]	郝跃伟刘雪平赵婷婷郑敏王一兵. 环氧化酶2基因多态性与动脉粥样硬化缺血性脑卒中的相关性[J]. 山东大学学报(医学版), 2209, 47(6): 95-98.
[4]	李军,李保敏,杨璐. UBA5 基因突变致早发性癫痫性脑病临床特征与遗传学分析[J]. 山东大学学报 (医学版), 2022, 60(8): 58-62.
[5]	王陆敏,周士英,黄启坤,刘艳丽. DNAH5基因新发突变致原发性纤毛运动障碍1例[J]. 山东大学学报 (医学版), 2022, 60(8): 103-108.
[6]	秦静,杨飞,陈谦,夏涵岱,刘延国,王秀问. 晚期驱动基因阴性、PD-L1表达阴性非鳞非小细胞肺癌一线治疗方案的网状Meta分析[J]. 山东大学学报 (医学版), 2022, 60(7): 74-82.
[7]	刘岩,张曼,姜朝阳,卞姝,杜艾家,陈鹤. LncRNA-HOTAIR调控H3K27me3影响巨噬细胞迁移的机制[J]. 山东大学学报 (医学版), 2022, 60(6): 1-9.
[8]	侯茹男,邵頔,秦廷廷,尚美美,申玉珍,孙晓杰. 山东省癌症患者烟草使用情况及影响因素分析[J]. 山东大学学报 (医学版), 2022, 60(6): 102-106.
[9]	唐钦连,张玉超,赵蕙琛,马小莉,于民民,刘元涛. 携带成对盒4基因突变早发糖尿病1例报道并文献复习[J]. 山东大学学报 (医学版), 2022, 60(5): 104-108.
[10]	任红,王伟,林岩,娄建伟,纪坤乾,赵玉英,焉传祝. Barth综合征1例报道[J]. 山东大学学报 (医学版), 2022, 60(4): 123-127.
[11]	郑昊天,王光辉,赵小刚,王亚东,曾榆凯,杜贾军. 基于数据库LKB1突变肺腺癌DNA异常甲基化位点构建的预后风险模型[J]. 山东大学学报 (医学版), 2022, 60(3): 51-58.
[12]	安袁笑雪,杜以明,田甜,张一,薛玉文. 肺炎奴卡菌合并天美奴卡菌肺部感染1例报道并文献复习[J]. 山东大学学报 (医学版), 2022, 60(3): 59-63.
[13]	钟黎黎,盛莹,郭江虹,阳双健,何宜静. LncRNA-UCA1通过靶向调控miR-182-5p对滋养细胞侵袭与转移的影响[J]. 山东大学学报 (医学版), 2022, 60(3): 76-82.
[14]	薛美娟,石艳,邵琳琳,王琳,张昀,张阿敏. 遗传性血栓性血小板减少性紫癜1例并文献复习[J]. 山东大学学报 (医学版), 2022, 60(3): 121-124.
[15]	王婧,刘小转,许芳芳. 肝豆状核变性的ATP7B基因变异分析及产前诊断[J]. 山东大学学报 (医学版), 2022, 60(2): 32-36.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed